Molbio Diagnostics Ltd. is a point-of-care diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases. Its platform Truenat include which is novel POC polymerase chain reaction that can operate in resource limited settings since its battery operated, facilitating decentralized diagnosis within an hour. The company was founded by Sriram Natarajan in 2000 and is headquartered in Verna, India.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Molbio Diagnostics Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Molbio Diagnostics Ltd. market cap is 133.95B.
What is the 52-week high for Molbio Diagnostics Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Molbio Diagnostics Ltd. 52 week high is 1,264.60 as of September 05, 2026.
What is the 52-week low for Molbio Diagnostics Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Molbio Diagnostics Ltd. 52 week low is 926.35 as of September 05, 2026.
What is Molbio Diagnostics Ltd. stock price today?
Molbio Diagnostics Ltd. stock price today is 1,158.90.
What was Molbio Diagnostics Ltd. stock price yesterday?
Molbio Diagnostics Ltd. stock price yesterday was 1,133.30.
What is the 50-day moving average of Molbio Diagnostics Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Molbio Diagnostics Ltd. 50-day moving average is 1,118.12.